| Literature DB >> 35053019 |
Abstract
The circadian clock is a fundamental biological timing mechanism that generates nearly 24 h rhythms of physiology and behaviors, including sleep/wake cycles, hormone secretion, and metabolism. Evolutionarily, the endogenous clock is thought to confer living organisms, including humans, with survival benefits by adapting internal rhythms to the day and night cycles of the local environment. Mirroring the evolutionary fitness bestowed by the circadian clock, daily mismatches between the internal body clock and environmental cycles, such as irregular work (e.g., night shift work) and life schedules (e.g., jet lag, mistimed eating), have been recognized to increase the risk of cardiac, metabolic, and neurological diseases. Moreover, increasing numbers of studies with cellular and animal models have detected the presence of functional circadian oscillators at multiple levels, ranging from individual neurons and fibroblasts to brain and peripheral organs. These oscillators are tightly coupled to timely modulate cellular and bodily responses to physiological and metabolic cues. In this review, we will discuss the roles of central and peripheral clocks in physiology and diseases, highlighting the dynamic regulatory interactions between circadian timing systems and multiple metabolic factors.Entities:
Keywords: SCN; brain clocks; circadian clock; circadian disruption; peripheral clocks; redox metabolism
Year: 2021 PMID: 35053019 PMCID: PMC8772734 DOI: 10.3390/biology11010021
Source DB: PubMed Journal: Biology (Basel) ISSN: 2079-7737
Figure 1Coupled-cellular oscillators. Bidirectional regulation between transcriptional and metabolic rhythms. The auto-regulatory feedback cycles between the CLOCK/BMAL1 transcriptional activator complex and its transcriptional repressors (PER/CRY, REV-ERBα) and activators (RORα/β), constituting the molecular clock oscillator. This oscillator drives the expression of multiple clock-controlled genes (CCGs), such as metabolic enzymes, ion channels, and transporters. The transcriptional rhythms (TR) mediate metabolic rhythms (MR) involving the cyclic synthesis, degradation, and transport (e.g., influx/efflux) of redox factors, gases, and ions, which, in turn, provide feedback that regulates the TR, constituting coupled-cellular oscillators.
Figure 2Coupled-tissue oscillators. Reciprocal crosstalk between the brain and peripheral clocks. The coupled TR and MR oscillators are thought to be commonly present across all body cells. Neurons and glial cells (e.g., astrocytes, microglia) interact to form the SCN central clock and non-SCN clocks in the brain. These autonomous brain clocks communicate with each other via neurotransmitters or neuropeptides, and with multiple peripheral tissue clocks via systemic innervations (ANS/SNS) or hormonal signals (e.g., cortisol, melatonin) in response to light–dark cycles. On the other hand, peripheral organs possess tissue autonomous clocks that can respond to non-photic physiological and environmental cues (e.g., temperature, food intake, exercise, stress) and provide feedback that influences the brain clocks via immune, metabolic, and endocrine signals. TR—transcriptional rhythms; MR—metabolic rhythms; ANS—autonomic nervous system; SNS—sympathetic nervous system.
A sampling of studies on the effects of tissue-specific Bmal1 ablation.
| Cell type of Selective Bmal1 Ablation | Promoter Controlling Cell-Specific Manipulation | Rhythm(s) Eliminated | Effect on Circadian Behavior | Clinical Manifestation | Citation Number |
|---|---|---|---|---|---|
| Adipocyte | Adipocyte protein 2 (aP2) gene promoter | Adiponectin | Shift in the diurnal rhythm of food intake and energy expenditure | Obesity | [ |
| Adrenal | Melanocortin 2 Receptor (MC2R) gene promoter, Aldosterone synthase (AS) gene promoter data | Circulating corticosterone, ACTH sensitivity | Attenuated behavioral rhythmicity | Hyperadrenocorticism | [ |
| Hepatocyte | Abumin (ABL) gene | Glucoregulatory genes | None | Increase glucose clearance and hypoglycemia restricted to the fasting phase | [ |
| Pancreatic β cell | Pancreatic Additionally, Duodenal Homeobox 1 (PDX1) gene promoter | Insulin secretion | None | Insulin resistance | [ |
| Skeletal muscle | Human α-skeletal actin (HSA) gene promoter | Muscle growth and metabolism | Sleep disturbance | Metabolic inefficiency and | [ |
| Renal | Kidney-specific cadherin (KSP-Cad) gene promoter | None | None | Altered the plasma metabolome, lowered blood pressure in male mice | [ |
| Intestine | Villin (VIL1) gene promoter | None | None | Prevents obesity induced by high-fat feeding | [ |
| Cardiomyocyte | Myosin heavy chain α (MHCα) gene promoter | Circadian gene | None | Diastolic dysfunction, Impaired resolution of inflammation, Reduced life span | [ |